A Blunt Assessment of Every Major ACCESS Model Participant, Their Business Models, and What CMS’s New Outcome-Aligned Payment Framework Actually Means for Their P&L and Patient Populations

Key Takeaways

• Virtual‑first CKM firms best positioned for OAP profitability
• Substitute Spend Adjustment penalizes participants lacking brick‑and‑mortar coordination
• Payers covering 165 million lives will align payments by 2028
• Outcome Attainment Threshold starts at 50% for first 18 months
• Older Medicare population raises clinical risk for outcome‑based models

Pulse Analysis

The ACCESS Model represents the most ambitious CMS Innovation Center experiment to date, pairing a ten‑year, voluntary framework with a novel Outcome‑Aligned Payment methodology. By bundling a fixed monthly per‑patient rate with a 50 percent withhold that is released only when participants meet predefined clinical targets, the program aims to shift incentives from volume to value. Four clinical tracks—early cardiometabolic, full cardiometabolic/diabetes/CKD, musculoskeletal pain, and behavioral health—cover the chronic conditions that drive the largest share of Medicare spending, making the model a potential catalyst for system‑wide cost containment.

Business implications diverge sharply between virtual‑first digital health companies and traditional brick‑and‑mortar providers. Companies that have already built commercial outcome‑based programs and own remote‑monitoring infrastructure can more readily meet the Outcome Attainment Thresholds. In contrast, pure‑play telehealth firms often lack deep relationships with local providers, exposing them to the Substitute Spend Adjustment, which penalizes any duplicated fee‑for‑service care. Effective coordination workflows and integrated care teams become essential to avoid the 90 percent SST penalty and to unlock the withheld payments.

The payer landscape amplifies the model’s significance. Fourteen major insurers representing 165 million covered lives have committed to align their commercial, Medicare Advantage and Medicaid reimbursement structures with ACCESS by January 1, 2028. This alignment creates a de‑facto national price signal that could accelerate adoption of technology‑enabled chronic‑care solutions. Participants that can demonstrate robust outcome data and seamless care coordination stand to capture substantial revenue, while those lagging may be forced out or compelled to partner with traditional providers. The ACCESS rollout will therefore serve as a litmus test for the scalability of outcome‑based payment across the U.S. health ecosystem.